The U.S. thoracic catheter market size was estimated at USD 164.28 million in 2024 and is projected to reach USD 269.05 million by 2033, growing at a CAGR of 5.73% from 2025 to 2033. This growth is driven by the rising prevalence of respiratory disorders, traumatic injuries, and postoperative complications that require efficient thoracic drainage solutions, along with the increasing demand for minimally invasive procedures that improve patient recovery times.
Advancements in catheter materials, such as silicone-based and antimicrobial-coated designs, are further enhancing safety and clinical outcomes, supporting higher adoption across hospitals and specialty clinics.
Chronic obstructive pulmonary disease is a significant driver of the U.S. thoracic catheter industry, as the condition often leads to complications such as pneumothorax, pleural effusion, and severe respiratory distress that require timely thoracic drainage. As COPD prevalence continues to rise due to aging populations, prolonged exposure to environmental pollutants, and high smoking rates, healthcare facilities are increasingly relying on thoracic catheters to manage these acute exacerbations and improve patient outcomes. Thoracic catheters play a critical role in relieving trapped air or fluid in the pleural space, enabling better lung expansion and respiratory function in COPD patients. The growing clinical need for efficient, minimally invasive drainage solutions in emergency care, intensive care units, and pulmonology practices directly supports higher utilization of advanced thoracic catheter systems, thereby accelerating overall market growth.
Traumatic injuries are a major factor driving the growth of the U.S. thoracic catheter industry, as chest trauma frequently leads to life-threatening conditions such as pneumothorax, hemothorax, and pleural effusion that require immediate thoracic drainage. Road accidents, falls, sports-related injuries, and workplace trauma often damage the ribs, lungs, or pleural cavity, creating an urgent need for chest tube placement to restore respiratory function and stabilize the patient. With trauma cases remaining a leading cause of emergency department admissions, hospitals increasingly depend on thoracic catheters for rapid decompression and effective fluid or air evacuation. The rise in high-impact injuries, coupled with improved trauma care protocols and expanding emergency medical services, is boosting the adoption of advanced catheter designs that offer safer insertion, lower infection risk, and quicker patient management.
According to the National Highway Traffic Safety Administration (NHTSA), an estimated 17,140 people lost their lives in motor vehicle crashes from January through June 2025, down from 18,680 fatalities during the same period in 2024.
This product will be delivered within 1-3 business days.
Advancements in catheter materials, such as silicone-based and antimicrobial-coated designs, are further enhancing safety and clinical outcomes, supporting higher adoption across hospitals and specialty clinics.
Chronic obstructive pulmonary disease is a significant driver of the U.S. thoracic catheter industry, as the condition often leads to complications such as pneumothorax, pleural effusion, and severe respiratory distress that require timely thoracic drainage. As COPD prevalence continues to rise due to aging populations, prolonged exposure to environmental pollutants, and high smoking rates, healthcare facilities are increasingly relying on thoracic catheters to manage these acute exacerbations and improve patient outcomes. Thoracic catheters play a critical role in relieving trapped air or fluid in the pleural space, enabling better lung expansion and respiratory function in COPD patients. The growing clinical need for efficient, minimally invasive drainage solutions in emergency care, intensive care units, and pulmonology practices directly supports higher utilization of advanced thoracic catheter systems, thereby accelerating overall market growth.
Traumatic injuries are a major factor driving the growth of the U.S. thoracic catheter industry, as chest trauma frequently leads to life-threatening conditions such as pneumothorax, hemothorax, and pleural effusion that require immediate thoracic drainage. Road accidents, falls, sports-related injuries, and workplace trauma often damage the ribs, lungs, or pleural cavity, creating an urgent need for chest tube placement to restore respiratory function and stabilize the patient. With trauma cases remaining a leading cause of emergency department admissions, hospitals increasingly depend on thoracic catheters for rapid decompression and effective fluid or air evacuation. The rise in high-impact injuries, coupled with improved trauma care protocols and expanding emergency medical services, is boosting the adoption of advanced catheter designs that offer safer insertion, lower infection risk, and quicker patient management.
According to the National Highway Traffic Safety Administration (NHTSA), an estimated 17,140 people lost their lives in motor vehicle crashes from January through June 2025, down from 18,680 fatalities during the same period in 2024.
U.S. Thoracic Catheter Market Report Segmentation
This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. thoracic catheter market report based on the material, product type, application, and end-use:Product Type Outlook (Revenue, USD Million, 2021-2033)
- Thoracostomy Tubes
- Pleural Drainage Catheters
- Others
Material Outlook (Revenue, USD Million, 2021-2033)
- Silicone
- Polyurethane
- PVC
- Others
Application Outlook (Revenue, USD Million, 2021-2033)
- Pneumothorax
- Pleural Effusion
- Hemothorax
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Thoracic Catheter Market Variables, Trends & Scope
Chapter 4. U.S. Thoracic Catheter Market: Material Estimates & Trend Analysis
Chapter 5. U.S. Thoracic Catheter Market: Product Type Estimates & Trend Analysis
Chapter 6. U.S. Thoracic Catheter Market: Application Estimates & Trend Analysis
Chapter 7. U.S. Thoracic Catheter Market: End Use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The key companies profiled in this U.S. Thoracic Catheter market report include:- Teleflex Incorporated
- Smiths Medical (ICU Medical, Inc.)
- B. Braun Melsungen AG
- Vygon SA
- Cook Medical
- Terumo Corporation
- Nipro Corporation
- Asahi Kasei Corporation
- Becton, Dickinson and Company
- Dongguan Jiajie Medical Tech Co., Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 164.28 Million |
| Forecasted Market Value ( USD | $ 269.05 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | United States |
| No. of Companies Mentioned | 11 |
